While EOAD represents a very small proportion of the AD patient population, the majority of animal models of AD have focused on monogenic mutations associated with EOAD (mutations in APP, PSEN 1, and PSEN 2) to model AD (Drummond and Wisniewski 2017). This evidence concerns the gene APP and Alzheimer disease.